Pathology News
Yale pathology researchers created a dependable test that precisely measures key proteins found in breast cancer cells that can help oncologists choose the most effective targeted therapies for patients, says a report published July 16 in Precision Oncology, a journal of the American Society of Clinical Oncology.
- July 16, 2025
A modified antibody-RNA therapy gets by the defenses of hard-to-reach and hard-to-treat cancers.
- July 11, 2025
A new study reveals a promising target for reducing amyloid beta buildup and preventing Alzheimer’s disease-like symptoms, such as brain fog, caused by COVID-19.
- July 10, 2025
A new Yale study found that open-source AI tools outperformed traditional, visual methods for measuring the abundance of melanoma biomarkers.
- July 10, 2025
Yale School of Medicine’s Department of Pathology has embraced the booming field of digital pathology, where digital scanners and AI are improving speed and accuracy.
- July 08, 2025Source: Yale Ventures
The mid-cycle Blavatnik Accelerator Awards recognize eight Yale early-stage innovations tackling cancer, rare disease, and neurodegeneration through digital platforms, RNA therapies, and next-gen molecules.
- July 07, 2025
In late June, about a dozen members of a Brazilian oncology program, Instituto Oncoclínicas, participated in an international exchange with members of Yale Cancer Center’s multi-disciplinary thoracic cancer program including discussions, presentations, mock and actual tumor board meetings, a tour of Smilow Cancer Hospital and a dinner at Mory's.
- July 02, 2025
Cancer fighting T cells, the immune system’s primary enforcers, are scarce in the rare kidney cancer called chromophobe renal cell carcinoma and those that are present are indifferent to the tumor threat and traditional immune therapies, revealing the need for new targets and treatments.
- July 01, 2025
The inaugural Workshop on Precision Diagnosis of Trophoblastic Disease, hosted by the Center for Precision Medicine of Trophoblastic Disease at Yale (Y-GTD), was a success, according to Pei Hui, MD, PhD, center director.
- July 01, 2025
The second edition of Gestational Trophoblastic Disease: Diagnostic and Molecular Genetic Pathology, edited by Pei Hui, MD, PhD, professor of pathology and of obstetrics, gynecology & reproductive sciences at Yale School of Medicine, has been published by Springer. The new edition offers substantial updates to this rapidly evolving field.